Patents
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
08/2010
08/19/2010US20100210495 Photo-labile pro-fragrance conjugates
08/18/2010CN101805320A Amide compounds and preparation method and applications thereof
08/18/2010CN101805268A Method for preparing acetyl salicylamide
08/17/2010US7776919 modulators of the interaction between the receptor for advanced glycated end products; 3-(4-Benzyloxyphenyl)propionic Acid 2,4- Di-(3-Diethylamino-1-propoxy)aniline Amide; acute and chronic inflammation; diabetic late complications; Alzheimer's disease, erectile dysfunction; metastasis
08/17/2010US7776918 Remedy for viral disease
08/17/2010US7776558 Human G protein-coupled receptor and modulators thereof for the treatment of cell death-related disorders
08/17/2010CA2527203C Casr antagonist
08/12/2010WO2010089984A1 Phenolic compound and recording material
08/12/2010US20100203650 Biomolecule binding ligands
08/11/2010EP2216322A1 Retinoid prodrug compound
08/11/2010EP2214810A1 Carbon nanotubes using for recovery of radionuclides and separation of actinides and lanthanides
08/11/2010CN101801918A Monoamide derivatives as orexin receptor antagonists
08/11/2010CN101801915A Process for the synthesis of na-beta-alaninate and calcium pantothenate
08/11/2010CN101006047B TRPV1 agonists, formulations containing them and uses thereof
08/10/2010US7772425 Vitamin D receptor modulators
08/10/2010US7772285 Benzophenone derivatives or salts thereof
08/05/2010WO2010087430A1 N-acyl anthranilic acid derivative or salt thereof
08/05/2010US20100197953 Levodopa prodrugs, and compositions and uses thereof
08/05/2010CA2750452A1 N-acyl anthranilic acid derivative or salt thereof
08/04/2010EP2213664A1 Process for the preparation of cyclopenta[g]quinazoline derivatives
08/04/2010CN101796019A Structural analogues of avenanthramides, their use in compositions useful in the treatment of dermatological disorders
08/04/2010CN101792401A Biphenyl compound with anti-tumor activity and preparation method thereof
08/03/2010US7767711 synthetic tea derived flavonoids, used for the of treatment of cancers; anticarcinogenic agents; enzyme inhibitors
08/03/2010US7767693 inhibition of heat shock protein 90 (HSP90) comprising administering benzoyl compounds or prodrugs,as antitumor agents
08/03/2010US7767650 Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
08/03/2010CA2512926C Methods and compositions for inhibition of angiogenesis
07/2010
07/28/2010EP2210597A2 Bacterial virulence modifying agents
07/27/2010US7763747 Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; Alzheimer's disease; diabetes; A beta amyloidosis
07/27/2010US7763659 N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
07/22/2010WO2010081683A1 Novel eicosanoid derivatives
07/22/2010WO2010009191A3 Fluorinated ether compounds and methods of using the same
07/22/2010US20100183712 Acylated indanyl amines and their use as pharmaceuticals
07/22/2010US20100183522 Contrast agents
07/22/2010CA2749840A1 Novel eicosanoid derivatives
07/21/2010EP2208727A1 Diaryl ethers as opioid receptor antagonist
07/21/2010EP2208720A1 Novel eicosanoid derivatives
07/21/2010EP2207540A1 Cyclopropyl aryl amide derivatives and uses thereof
07/21/2010CN1826310B Novel aminobenzophenone compounds
07/20/2010US7759519 Amide and peptide derivatives of dialkylenetriamines and their use as transfection agents
07/20/2010US7759514 peptidomimetics such as (Z)-8-Amino-2-benzyl-3,7-dihydroxy-9-(4-hydroxy-phenyl)-non-4-enoic acid (1-carbamoyl-2-phenyl-ethyl)-amide, having improved selectivity to targets, improved bioavailability and lessened adverse side effects, used as analgesics
07/20/2010CA2486399C Calcium receptor modulating agents
07/15/2010US20100179326 Benzamide derivative
07/14/2010EP2205088A1 Naphthalene-based inhibitors of anti-apoptotic proteins
07/14/2010EP1951659B1 Glucagon receptor antagonists, preparation and therapeutic uses
07/14/2010EP1891026B1 Cycloalkylidene compounds as selective estrogen receptor modulators
07/13/2010US7754823 coating formulations and polymers that utilize a dioxanone containing composition or fatty acid derivative
07/13/2010US7754772 (2R)-2,3-bis(nitrooxy)propyl(2S)-2(6-methoxy(2-naphthyl)propanoate, used for treating inflammation, pain and fever; gastrointestinal disorders; wound healing agents; preventing gastrointestinal, renal and/or respiratory toxicities; side effect reduction
07/13/2010US7754771 Compounds for the treatment of AIDS and other viral diseases
07/13/2010CA2444244C Methods of synthesizing acylanilides including bicalutamide and derivatives thereof
07/08/2010US20100173985 Polyphenol proteasome inhibitors, synthesis, and methods of use
07/07/2010EP1256569B1 Phenacylamine derivatives, production thereof and pest controllers containing the derivatives
07/07/2010CN101768088A Phthalic acid derivative and agricultural and horticultural pesticide and application method thereof
07/07/2010CN101768075A 15-carbonyl steviol derivative and salt as well as preparation method and application
07/06/2010US7750181 Antiproliferative agents
07/06/2010US7750047 benzoic acid derivatives, used as acetyltransferase enzyme inhibitors, used in the treatment of diseases due to defects in gene regulation predominantly cancer
07/01/2010WO2010073934A1 Fluorine-containing compound, fluorine-containing polymer compound, resist composition and patterning method using same
07/01/2010WO2010072810A1 Mixture of amides and cosmetic compositions comprising said mixture
07/01/2010WO2009053808A3 Histone deacetylase inhibitors
07/01/2010US20100166706 Hcv ns-3 serine protease inhibitors
06/2010
06/30/2010EP2202219A1 Mixture of amides and cosmetic compositions comprising said mixture
06/30/2010EP2202216A1 Spiro-ring compound and use thereof for medical purposes
06/30/2010EP2200969A2 Novel compounds active as muscarinic receptor antagonists
06/30/2010CN101759594A Method for synthesizing allosteric hemoglobin synergist efaproxiral
06/30/2010CN101759593A Method for synthesizing bilateral divergent dendrimer nucleus
06/30/2010CN101186586B N,N'-difluorophenyl derivative of 4-methoxyl-1,3-phthalamide and use thereof
06/29/2010US7745663 mitogen-activated protein kinase inhibitors such as 3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-N-(2-hydroxy-ethoxy)-5(2-hydroxy-ethoxymethyl)-benzamide, used to treat proliferative diseases, for example, cancers, psoriasis, restenosis, autoimmune diseases and atherosclerosis
06/29/2010US7745662 Polycationic compounds and uses thereof
06/29/2010US7745490 3-hydroxy-N-(3-hydroxy-4-methoxyphenyl)-4-methoxybenzamide, used in the treatment of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyloidosis, such as observed non-insulin depepndent diabetes
06/29/2010US7745489 Potent 2-oxo-amide based compounds; abrogating prostaglandin production; low dosage; spinal cord and central nervous system pain
06/29/2010US7745488 Therapy for neutropenia as result of radiation therapy; administering colony stimulating factor
06/29/2010US7744910 Compounds and compositions for delivering active agents
06/24/2010WO2010070615A1 Cysteine protease inhibitors
06/24/2010US20100160327 Modified Malonate Derivatives
06/24/2010US20100160285 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease
06/24/2010US20100158996 Ester compound and medical use thereof
06/24/2010CA2744888A1 Cysteine protease inhibitors
06/23/2010CN1805931B Process and intermediates for the preparation of (1r,2s,5s)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof
06/22/2010US7741454 Biological low-molecular-weight derivatives
06/22/2010US7741352 for the treatment or alleviation of pain, headaches, nervous system disorders or trauma, stroke, neurodegenerative diseases, cardiovascular disorders, inflammatory diseases, vision defects, hearing disorders, respiratory system disordres and urinary incontinence
06/22/2010CA2462149C Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth
06/22/2010CA2374346C Inhibitors of memapsin 2 and use thereof
06/17/2010WO2010068183A1 Glucose-peg conjugates for reducing glucose transport into a cell
06/17/2010WO2010067589A1 Method for producing β-alkoxypropionamide
06/17/2010WO2010066847A1 Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-hiv agents
06/17/2010US20100152254 Alpha-halo- and alpha-alkyl-cyclopropylcarboxy compounds and uses thereof
06/16/2010EP2196454A2 Exo-and diastereo-selective syntheses of himbacine analogs
06/16/2010EP2196453A1 Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-HIV agents
06/16/2010EP1091924B1 Novel retinoids and use thereof
06/16/2010CN1871221B N-substituted pyrazolyl carboxanilides
06/16/2010CN101743219A Optically active (R)-aryloxypropionic acid amides and herbicidal composition comprising same
06/16/2010CN101735100A Taspine biphenyl derivative and preparation method thereof
06/15/2010US7737135 (2S)-2-[[4'-(methylsulfonyl)-3',5-bis(trifluoromethyl)[1,1'-biphenyl]-2-yl]oxy]-propanoic acid for example; asthma or rhinitis; orphan receptor CRTH2 modulators, prostaglandin D2 is a ligand of CRTH2
06/10/2010WO2010065117A1 Inhibition of hdac2 to promote memory
06/10/2010US20100145056 Acetyl 2-hydroxy-1,3-diaminoalkanes
06/10/2010US20100145048 Compounds for the treatment of inflammatory disorders
06/10/2010US20100144876 Modulator
06/10/2010US20100143387 Multimeric conjugate
06/10/2010DE112008001983T5 Verfahren für die Synthese von Na-beta-Alaninat und Calciumpantothenat A method for the synthesis of Na-beta-alaninate and calcium pantothenate
06/09/2010CN1914152B New compounds, methods for their preparation and use thereof
06/09/2010CN101723850A Novel 18F labeled aromatic amino acids, preparation method and application thereof in tumor imaging
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 157